Literature DB >> 11416224

Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.

K Lewis1, C Li, M H Perrin, A Blount, K Kunitake, C Donaldson, J Vaughan, T M Reyes, J Gulyas, W Fischer, L Bilezikjian, J Rivier, P E Sawchenko, W W Vale.   

Abstract

The corticotropin-releasing factor (CRF) family of neuropeptides includes the mammalian peptides CRF, urocortin, and urocortin II, as well as piscine urotensin I and frog sauvagine. The mammalian peptides signal through two G protein-coupled receptor types to modulate endocrine, autonomic, and behavioral responses to stress, as well as a range of peripheral (cardiovascular, gastrointestinal, and immune) activities. The three previously known ligands are differentially distributed anatomically and have distinct specificities for the two major receptor types. Here we describe the characterization of an additional CRF-related peptide, urocortin III, in the human and mouse. In searching the public human genome databases we found a partial expressed sequence tagged (EST) clone with significant sequence identity to mammalian and fish urocortin-related peptides. By using primers based on the human EST sequence, a full-length human clone was isolated from genomic DNA that encodes a protein that includes a predicted putative 38-aa peptide structurally related to other known family members. With a human probe, we then cloned the mouse ortholog from a genomic library. Human and mouse urocortin III share 90% identity in the 38-aa putative mature peptide. In the peptide coding region, both human and mouse urocortin III are 76% identical to pufferfish urocortin-related peptide and more distantly related to urocortin II, CRF, and urocortin from other mammalian species. Mouse urocortin III mRNA expression is found in areas of the brain including the hypothalamus, amygdala, and brainstem, but is not evident in the cerebellum, pituitary, or cerebral cortex; it is also expressed peripherally in small intestine and skin. Urocortin III is selective for type 2 CRF receptors and thus represents another potential endogenous ligand for these receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11416224      PMCID: PMC34709          DOI: 10.1073/pnas.121165198

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Neural network prediction of translation initiation sites in eukaryotes: perspectives for EST and genome analysis.

Authors:  A G Pedersen; H Nielsen
Journal:  Proc Int Conf Intell Syst Mol Biol       Date:  1997

Review 2.  Peptide chemistry: development of high performance liquid chromatography and capillary zone electrophoresis.

Authors:  C Miller; J Rivier
Journal:  Biopolymers       Date:  1996       Impact factor: 2.505

3.  Neuroendocrine responses to an emotional stressor: evidence for involvement of the medial but not the central amygdala.

Authors:  C V Dayas; K M Buller; T A Day
Journal:  Eur J Neurosci       Date:  1999-07       Impact factor: 3.386

4.  Peripheral urocortin delays gastric emptying: role of CRF receptor 2.

Authors:  T Nozu; V Martinez; J Rivier; Y Taché
Journal:  Am J Physiol       Date:  1999-04

5.  The second messenger cAMP elicits eating by an anatomically specific action in the perifornical hypothalamus.

Authors:  E R Gillard; A M Khan; R S Grewal; B Mouradi; S D Wolfsohn; B G Stanley
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

6.  Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression.

Authors:  D T Chalmers; T W Lovenberg; E B De Souza
Journal:  J Neurosci       Date:  1995-10       Impact factor: 6.167

7.  Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.

Authors:  J Vaughan; C Donaldson; J Bittencourt; M H Perrin; K Lewis; S Sutton; R Chan; A V Turnbull; D Lovejoy; C Rivier
Journal:  Nature       Date:  1995-11-16       Impact factor: 49.962

8.  Pituitary follistatin and inhibin subunit messenger ribonucleic acid levels are differentially regulated by local and hormonal factors.

Authors:  L M Bilezikjian; A Z Corrigan; A L Blount; W W Vale
Journal:  Endocrinology       Date:  1996-10       Impact factor: 4.736

9.  Organization of projections from the medial nucleus of the amygdala: a PHAL study in the rat.

Authors:  N S Canteras; R B Simerly; L W Swanson
Journal:  J Comp Neurol       Date:  1995-09-18       Impact factor: 3.215

10.  Ligand requirements of the human corticotropin-releasing factor-binding protein.

Authors:  S W Sutton; D P Behan; S L Lahrichi; R Kaiser; A Corrigan; P Lowry; E Potter; M H Perrin; J Rivier; W W Vale
Journal:  Endocrinology       Date:  1995-03       Impact factor: 4.736

View more
  243 in total

1.  Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression.

Authors:  Chien Li; Joan Vaughan; Paul E Sawchenko; Wylie W Vale
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

2.  NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor.

Authors:  Christy R R Grace; Marilyn H Perrin; Michael R DiGruccio; Charleen L Miller; Jean E Rivier; Wylie W Vale; Roland Riek
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

Review 3.  Structure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptors.

Authors:  Kuntal Pal; Karsten Melcher; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2012-01-23       Impact factor: 6.150

Review 4.  Minireview: CRF and Wylie Vale: a story of 41 amino acids and a Texan with grit.

Authors:  Tracy L Bale; Alon Chen
Journal:  Endocrinology       Date:  2012-04-04       Impact factor: 4.736

Review 5.  Tobacco addiction and the dysregulation of brain stress systems.

Authors:  Adrie W Bruijnzeel
Journal:  Neurosci Biobehav Rev       Date:  2012-03-03       Impact factor: 8.989

6.  Perifornical Urocortin-3 mediates the link between stress-induced anxiety and energy homeostasis.

Authors:  Yael Kuperman; Orna Issler; Limor Regev; Ifat Musseri; Inbal Navon; Adi Neufeld-Cohen; Shosh Gil; Alon Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

Review 7.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

8.  Urocortin 2 Gene Transfer Reduces the Adverse Effects of a Western Diet on Cardiac Function in Mice.

Authors:  Young Chul Kim; Dimosthenis Giamouridis; N Chin Lai; Tracy Guo; Bing Xia; Zhenxing Fu; Mei Hua Gao; H Kirk Hammond
Journal:  Hum Gene Ther       Date:  2019-03-11       Impact factor: 5.695

9.  Cardiac CRFR1 Expression Is Elevated in Human Heart Failure and Modulated by Genetic Variation and Alternative Splicing.

Authors:  Anna P Pilbrow; Kathy A Lewis; Marilyn H Perrin; Wendy E Sweet; Christine S Moravec; W H Wilson Tang; Mark O Huising; Richard W Troughton; Vicky A Cameron
Journal:  Endocrinology       Date:  2016-10-18       Impact factor: 4.736

Review 10.  Corticotropin-releasing hormone-binding protein and stress: from invertebrates to humans.

Authors:  Kyle D Ketchesin; Gwen S Stinnett; Audrey F Seasholtz
Journal:  Stress       Date:  2017-05-18       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.